C 26 H 28 Cl 2 N 2 O 3 , monoclinic, P2 1 /c (no. 14), a = 13.422(3) Å, b = 7.0011(14) Å, c = 26.249(5) Å, β = 101.06(3)°, V = 2420.8(9) Å 3 , Z = 4, R gt (F) = 0. The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. CN, 10 mL) was added 1-(3-chlorophenyl)piperazine (1.2 equiv) and potassium carbonate (6.0 equiv). The reaction mixture was stirred at reflux for 16 h. After cooling to ambient temperature, the reaction mixture was filtered through a Büchner funnel. After filtration the filtrate was concentrated in vacuo and the residue was purified by silica gel column chromatography using ethyl acetate/petroleum ether (1/5, v/v) as eluent to afford the product, and the title compound was recrystallized from trichloromethane and n-hexane [3] .
CCDC no.: 1402519
The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. [1, 3] dioxol-5-yloxy)methyl)phenyl)ethyl 4-methylbenzenesulfonate (100 mg, 0.23 mmol) in acetonitrile (CH 3 CN, 10 mL) was added 1-(3-chlorophenyl)piperazine (1.2 equiv) and potassium carbonate (6.0 equiv). The reaction mixture was stirred at reflux for 16 h. After cooling to ambient temperature, the reaction mixture was filtered through a Büchner funnel. After filtration the filtrate was concentrated in vacuo and the residue was purified by silica gel column chromatography using ethyl acetate/petroleum ether (1/5, v/v) as eluent to afford the product, and the title compound was recrystallized from trichloromethane and n-hexane [3] .
Experimental details
The hydrogen atoms were assigned with isotropic displacement factors U iso (H) = 1.2U eq (N and imidazol C), or U iso (H) = 1.5U eq (methyl C) and included in the final refinements by using geometrical restraints, with C-H = 0.93 Å (imidazol) or C-H = 0.96 Å (methyl), and N-H = 0.86 Å. 
Discussion
Compounds with arylpiperazine moieties have a wide range of activities including antiarrhythmic [4] , diuretic [5] , antiallergic [6] , antidepressant [7] , anxiolytic [8] , antipsychotic [9] , antimalarial [10] , antiplasmodial [11] and anti-proliferative [12] [13] [14] properties. In addition, these compounds also display receptor-blocking properties [15] [16] [17] [18] [19] . Moreover, arylpiperazine derivatives have been reported as anticancer drugs for site-directed chemotherapy of prostate cancer in our previous work [20, 21] , and some derivatives showed significant cytotoxic activity against the tested prostate cancer cell lines. Bond lengths and all other geometic parameters of the title molecule are in the expected ranges [22] .
